- Flavoxate
drugbox
IUPAC_name = 2-(1-piperidyl)ethyl 3-methyl-4-oxo-2-phenyl-chromene-8-carboxylate
CAS_number = 15301-69-6
ATC_prefix = G04
ATC_suffix = BD02
ATC_supplemental =
PubChem = 3354
DrugBank = APRD00972
C=24 | H=25 | N=1 | O=4
molecular_weight = 391.46 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
pregnancy_category =
legal_status =
routes_of_administration =Flavoxate is an
anticholinergic with antimuscarinic effects. Itsmuscle relaxant properties may be due to a direct action on the smooth muscle rather than by antagonizing muscarinic receptors.Clinical uses
Flavoxate is used to treat urinary bladder spasms. It is available under the trade name Urispas (Paladin),Uritac by El Saad company in Syria, or under the name Bladderon by
Nippon Shinyaku of Japan.Flavoxate HCl is indicated for symptomatic relief of
interstitial cystitis , dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.Adverse ReactionsThe following adverse reactions have been observed, but there are not enough data to support an estimate of their frequency.Nausea, vomiting, dry mouth vertigo, headache, mental confusion, especially in the elderly, drowsiness, nervousness. tachycardia and palpitation. urticaria and other dermatoses, eosinophilia and hyperpyrexia, increased ocular tension, blurred vision, disturbance in eye accommodation and dysuria.
Contraindications:Flavoxate HCl is contraindicated in patients who have any of the following obstructive conditions: pyloric or duodenal obstruction, obstructive intestinal lesions or ileus, achalasia, gastrointestinal hemorrhage and obstructive uropathies of the lower urinary tract.
ources
*Brenner, G. M. (2000). "Pharmacology." Philadelphia, PA: W.B. Saunders Company. ISBN 0-7216-7757-6
*Canadian Pharmacists Association (2000). "Compendium of Pharmaceuticals and Specialties" (25th ed.). Toronto, ON: Webcom. ISBN 0-919115-76-4
Wikimedia Foundation. 2010.
